COVID-19 quick takes--part three
February 13, 2021
This HND piece continues on from the previous week, this time looking at a ridiculous mask study from the CDC; Pfizer deciding not to pursue the India market for its vaccine; and the WHO inspection of the Wuhan Lab.
We reveal a serious issue with that CDC, that is hiding in plain site, and was missed by almost every single media outlet that covered it. One has to wonder why Pfizer would bail on the world's second most populated country, to sell more of its vaccines. And as to the WHO inspection, let's just say that it was...flawed.
Read the complete article.